Reuters logo
BRIEF-Ajanta Pharma says U.S. unit launches eletriptan hydrobromide tablets
August 31, 2017 / 5:17 AM / in 2 months

BRIEF-Ajanta Pharma says U.S. unit launches eletriptan hydrobromide tablets

Aug 31 (Reuters) - Ajanta Pharma Ltd

* Says launched eletriptan hydrobromide tablets in US market through our wholly owned subsidiary, Ajanta Pharma USA Inc. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below